02 Jan 2023 — Vienna-based Arkeon has received an additional €4 million (US$4.27 million) in capital to advance its CO2 utilization technology, which converts carbon dioxide into protein ingredients. To date, the company has accumulated over €10 million (US$10.69 million) in funding for its technology buildout, infrastructure expansion, and product development, as it works to disrupt food production on a global scale.
Arkeon says that by producing functional, nutritious and environmentally sustainable protein ingredients, it can transition industries that require a lot of resources to low-emission systems.
“Our current focus is to scale up the amino acid production process with our archaea. The next concrete step is to realize a 150 L bioreactor operation in Q1 of 2023. The next bigger bioreactor (3000 L) is already in the conception phase. In parallel, preliminary work is already underway to produce tailor-made peptides from our amino acids,” a spokesperson from Arkeon tells NutritionInsight.
Additionally, the protein can be used as clean-label ingredients for food and beverages, alternative proteins, flavors and aromas, supplements, and cell culture media for cultivated meat, the company details.
** Click here to read the full text **
